CONJUCHEM, LLC

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 5250
 
  
 
C07D HETEROCYCLIC COMPOUNDS 2160
 
  
 
C07K PEPTIDES 2134

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
6107489 Extended lifetimes in vivo renin inhibitorsMar 12, 99Aug 22, 00[A61K, C07D]
6103233 Cellular and serum protein anchors and conjugatesJun 07, 95Aug 15, 00[A61K, C07K]
6087375 Methods of treating or preventing thrombosesJun 11, 99Jul 11, 00[A61K, C07D]
5843440 Cellular and serum protein anchors for modulating pharmacokineticsAug 14, 96Dec 01, 98[A61K, C07K]
5612034 Super-globuling for in vivo extended lifetimesMay 03, 94Mar 18, 97[A61K]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
8093206 Methods involving long lasting synthetic exendin-4 peptide conjugatesExpiredDec 14, 05Jan 10, 12[A61K]
8084414 Methods involving long lasting synthetic exendin-4-peptide conjugatesExpiredAug 30, 05Dec 27, 11[A61K]
8080516 Long lasting synthetic exendin-4 peptide conjugatesExpiredJun 29, 05Dec 20, 11[A61K]
8039432 Method of treatment of diabetes and/or obesity with reduced nausea side effectExpiredNov 09, 06Oct 18, 11[A61K]
7982018 Modified corticotropin releasing factor peptides and uses thereofExpiredOct 16, 07Jul 19, 11[A61K, C07K]
2011/0166,061 LONG LASTING FUSION PEPTIDE INHIBITORS FOR HIV INFECTIONAbandonedApr 26, 10Jul 07, 11[A61K, A61P, C07K]
2011/0071,082 LONG LASTING ANTI-ANGIOGENIC PEPTIDESAbandonedApr 13, 10Mar 24, 11[A61K, A61P, C07K]
7906482 Anti-obesity agentsExpiredOct 24, 07Mar 15, 11[A61K, C07K]
7741286 Long lasting anti-angiogenic peptidesExpiredFeb 08, 06Jun 22, 10[A61K]
7741453 Long lasting fusion peptide inhibitors for HIV infectionExpiredMay 31, 02Jun 22, 10[C08H]
7737251 Long lasting glucagon-like peptide 2 (GLP-2) for the treatment of gastrointestinal diseases and disordersExpiredDec 23, 05Jun 15, 10[A61K]
2009/0312,259 LONG LASTING GLUCAGON-LIKE PEPTIDE 2 (GLP-2) FOR THE TREATMENT OF GASTROINTESTINAL DISEASES AND DISORDERSAbandonedJul 19, 09Dec 17, 09[A61K, C07K]
2009/0275,506 LONG LASTING NATRIURETIC PEPTIDE DERIVATIVESAbandonedOct 17, 08Nov 05, 09[A61K, C07K]
7608271 Modified human immunodeficiency virus anti-fusogenic GP41 peptides comprising a maleimide-containing groupExpiredSep 24, 04Oct 27, 09[A61K]
7601691 Anti-obesity agentsExpiredFeb 25, 05Oct 13, 09[A61K, C07K]
7582301 Long-lasting antiviral fusion inhibitor peptide conjugates comprising albumin and human immunodeficiency virus (HIV) peptidesExpiredMay 17, 00Sep 01, 09[A61K]
2009/0186,819 FORMULATION OF INSULINOTROPIC PEPTIDE CONJUGATESAbandonedDec 11, 08Jul 23, 09[A61K, A61P]
2009/0175,821 Modified therapeutic peptides with extended half-lives in vivoAbandonedOct 31, 07Jul 09, 09[A61K, C07K]
2009/0093,408 Protection of exendin-4 peptides through conjugationAbandonedAug 01, 08Apr 09, 09[A61K, C07K]
2009/0088,377 CYSTEIC ACID DERIVATIVES OF ANTI-VIRAL PEPTIDESAbandonedMay 16, 08Apr 02, 09[A61K, C07K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.